Almirall, Forest Get EU, FDA Nods For COPD Treatment
Almirall SA and Forest Laboratories Inc.'s inhaled chronic obstructive pulmonary disease drug received U.S. Food and Drug Administration and European regulatory approval this week, the companies announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article